Pfizer (PFE) Tops Q2 EPS by 7c, Updates Guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $24.86 -0.88%
EPS Growth %: -12.8%
Financial Fact:
Research and development expenses: 1.88B
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: -12.8%
Financial Fact:
Research and development expenses: 1.88B
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q2 EPS of $0.81, $0.07 better than the analyst estimate of $0.74. Revenue for the quarter came in at $13.47 billion versus the consensus estimate of $13.31 billion.
GUIDANCE:
Pfizer sees FY2018 EPS of $2.95-$3.05, versus the consensus of $2.95. Pfizer sees FY2018 revenue of $53-55 billion, versus the consensus of $54.3 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- William Blair Upgrades Backblaze Inc (BLZE) to Market Perform
- Worthington Enterprises raises dividend 5%, adds board member
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
